nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—vagus nerve—epilepsy syndrome	0.0627	0.435	CbGeAlD
Fosaprepitant—TACR1—ganglion—epilepsy syndrome	0.0242	0.168	CbGeAlD
Fosaprepitant—TACR1—brainstem—epilepsy syndrome	0.0105	0.0729	CbGeAlD
Fosaprepitant—TACR1—forebrain—epilepsy syndrome	0.0101	0.0703	CbGeAlD
Fosaprepitant—TACR1—telencephalon—epilepsy syndrome	0.00933	0.0647	CbGeAlD
Fosaprepitant—TACR1—spinal cord—epilepsy syndrome	0.00653	0.0453	CbGeAlD
Fosaprepitant—TACR1—head—epilepsy syndrome	0.00581	0.0403	CbGeAlD
Fosaprepitant—TACR1—nervous system—epilepsy syndrome	0.00551	0.0382	CbGeAlD
Fosaprepitant—TACR1—central nervous system—epilepsy syndrome	0.0053	0.0368	CbGeAlD
Fosaprepitant—Aprepitant—CYP2C19—epilepsy syndrome	0.00426	1	CrCbGaD
Fosaprepitant—TACR1—brain—epilepsy syndrome	0.00421	0.0292	CbGeAlD
Fosaprepitant—TACR1—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000561	0.00195	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000556	0.00194	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—GABBR1—epilepsy syndrome	0.000546	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.000543	0.00189	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.000543	0.00189	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000533	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000533	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000532	0.00185	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HRH3—epilepsy syndrome	0.000524	0.00182	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—epilepsy syndrome	0.000522	0.00182	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000517	0.0018	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000515	0.00179	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR10—epilepsy syndrome	0.000511	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000511	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.000511	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000502	0.00175	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000492	0.00171	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000491	0.00171	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000489	0.0017	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR3—epilepsy syndrome	0.000487	0.00169	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AGT—epilepsy syndrome	0.000485	0.00169	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—epilepsy syndrome	0.000476	0.00166	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—NPY—epilepsy syndrome	0.000474	0.00165	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000463	0.00161	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL3—epilepsy syndrome	0.000458	0.00159	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—OXT—epilepsy syndrome	0.000458	0.00159	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CRH—epilepsy syndrome	0.000458	0.00159	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000458	0.00159	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM2—epilepsy syndrome	0.000447	0.00156	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000445	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—epilepsy syndrome	0.000443	0.00154	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CASP3—epilepsy syndrome	0.000442	0.00154	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000439	0.00153	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000427	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000427	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000427	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000427	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000427	0.00149	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000419	0.00146	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000419	0.00146	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—epilepsy syndrome	0.000418	0.00145	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—SST—epilepsy syndrome	0.000414	0.00144	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR2—epilepsy syndrome	0.000414	0.00144	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000412	0.00143	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000411	0.00143	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.000408	0.00142	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000405	0.00141	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000404	0.00141	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000404	0.00141	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	0.000399	0.00139	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRDM4—epilepsy syndrome	0.000399	0.00139	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000399	0.00139	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000397	0.00138	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000389	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000389	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000388	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000388	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR9—epilepsy syndrome	0.000388	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000388	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR8—epilepsy syndrome	0.000388	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CNR1—epilepsy syndrome	0.000382	0.00133	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM3—epilepsy syndrome	0.00038	0.00132	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM4—epilepsy syndrome	0.00038	0.00132	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000379	0.00132	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000373	0.0013	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR7—epilepsy syndrome	0.000373	0.0013	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000363	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000363	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000363	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000363	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM8—epilepsy syndrome	0.00036	0.00125	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.000355	0.00123	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.000354	0.00123	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.00035	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ACKR4—epilepsy syndrome	0.000348	0.00121	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000344	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000344	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.000344	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000343	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GAL—epilepsy syndrome	0.000341	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000337	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000337	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CHRM1—epilepsy syndrome	0.00033	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDYN—epilepsy syndrome	0.00033	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM1—epilepsy syndrome	0.00033	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR7—epilepsy syndrome	0.00033	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000325	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—epilepsy syndrome	0.000322	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000317	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000317	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SSTR4—epilepsy syndrome	0.000315	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SSTR5—epilepsy syndrome	0.000315	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AVP—epilepsy syndrome	0.000314	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GAL—epilepsy syndrome	0.00031	0.00108	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000309	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GRM5—epilepsy syndrome	0.000306	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000306	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR10—epilepsy syndrome	0.000302	0.00105	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.0003	0.00104	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000296	0.00103	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000294	0.00102	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000291	0.00101	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000288	0.001	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000288	0.001	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000288	0.001	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GABBR1—epilepsy syndrome	0.00028	0.000975	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000275	0.000957	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000274	0.000953	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HRH3—epilepsy syndrome	0.000269	0.000935	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPY—epilepsy syndrome	0.000268	0.000933	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000268	0.000932	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—epilepsy syndrome	0.000267	0.000928	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000264	0.000921	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM2—epilepsy syndrome	0.000264	0.000919	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000261	0.000908	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000259	0.0009	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CRH—epilepsy syndrome	0.000259	0.0009	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—OXT—epilepsy syndrome	0.000259	0.0009	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.000257	0.000895	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR3—epilepsy syndrome	0.00025	0.000869	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AGT—epilepsy syndrome	0.000248	0.000862	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPY—epilepsy syndrome	0.000243	0.000847	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SSTR3—epilepsy syndrome	0.000239	0.000831	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—OXT—epilepsy syndrome	0.000235	0.000817	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CRH—epilepsy syndrome	0.000235	0.000817	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000235	0.000817	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL3—epilepsy syndrome	0.000235	0.000817	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SST—epilepsy syndrome	0.000234	0.000814	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000234	0.000814	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000234	0.000813	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR9—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR8—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000229	0.000797	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM3—epilepsy syndrome	0.000225	0.000782	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM4—epilepsy syndrome	0.000225	0.000782	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DUSP4—epilepsy syndrome	0.00022	0.000767	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SSTR2—epilepsy syndrome	0.00022	0.000767	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.00022	0.000765	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.00022	0.000765	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000216	0.000751	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000215	0.000749	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM8—epilepsy syndrome	0.000213	0.000741	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PGF—epilepsy syndrome	0.000213	0.000741	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SST—epilepsy syndrome	0.000212	0.000739	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000212	0.000739	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000211	0.000733	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—epilepsy syndrome	0.000208	0.000725	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000208	0.000723	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000204	0.00071	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000203	0.000707	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000203	0.000707	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000201	0.000698	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.0002	0.000695	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.0002	0.000695	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000196	0.000682	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000195	0.00068	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000195	0.000678	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR7—epilepsy syndrome	0.000195	0.000678	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDYN—epilepsy syndrome	0.000195	0.000678	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM1—epilepsy syndrome	0.000195	0.000678	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000191	0.000666	CbGpPWpGaD
Fosaprepitant—Headache—Fosphenytoin—epilepsy syndrome	0.000187	0.000331	CcSEcCtD
Fosaprepitant—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000187	0.000331	CcSEcCtD
Fosaprepitant—Palpitations—Pregabalin—epilepsy syndrome	0.000186	0.00033	CcSEcCtD
Fosaprepitant—Asthenia—Phenytoin—epilepsy syndrome	0.000186	0.00033	CcSEcCtD
Fosaprepitant—Nausea—Midazolam—epilepsy syndrome	0.000186	0.000329	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000186	0.000329	CcSEcCtD
Fosaprepitant—Muscle spasms—Gabapentin—epilepsy syndrome	0.000186	0.000329	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000186	0.000646	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Zonisamide—epilepsy syndrome	0.000185	0.000329	CcSEcCtD
Fosaprepitant—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000185	0.000328	CcSEcCtD
Fosaprepitant—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000185	0.000328	CcSEcCtD
Fosaprepitant—Pruritus—Clonazepam—epilepsy syndrome	0.000185	0.000328	CcSEcCtD
Fosaprepitant—Vomiting—Vigabatrin—epilepsy syndrome	0.000185	0.000327	CcSEcCtD
Fosaprepitant—Skin disorder—Valproic Acid—epilepsy syndrome	0.000185	0.000327	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000184	0.000327	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000184	0.000326	CcSEcCtD
Fosaprepitant—Cough—Pregabalin—epilepsy syndrome	0.000184	0.000326	CcSEcCtD
Fosaprepitant—Pruritus—Phenytoin—epilepsy syndrome	0.000184	0.000325	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000183	0.000325	CcSEcCtD
Fosaprepitant—Nausea—Levetiracetam—epilepsy syndrome	0.000183	0.000325	CcSEcCtD
Fosaprepitant—Rash—Vigabatrin—epilepsy syndrome	0.000183	0.000325	CcSEcCtD
Fosaprepitant—Dizziness—Felbamate—epilepsy syndrome	0.000183	0.000325	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000183	0.000637	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GAL—epilepsy syndrome	0.000183	0.000637	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GFAP—epilepsy syndrome	0.000183	0.000637	CbGpPWpGaD
Fosaprepitant—Dermatitis—Vigabatrin—epilepsy syndrome	0.000183	0.000324	CcSEcCtD
Fosaprepitant—Urethral disorder—Topiramate—epilepsy syndrome	0.000183	0.000324	CcSEcCtD
Fosaprepitant—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000183	0.000324	CcSEcCtD
Fosaprepitant—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000182	0.000323	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000182	0.000634	CbGpPWpGaD
Fosaprepitant—Headache—Vigabatrin—epilepsy syndrome	0.000182	0.000323	CcSEcCtD
Fosaprepitant—Hypertension—Pregabalin—epilepsy syndrome	0.000182	0.000322	CcSEcCtD
Fosaprepitant—Vomiting—Diazepam—epilepsy syndrome	0.000182	0.000322	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CASP2—epilepsy syndrome	0.000181	0.00063	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GRM5—epilepsy syndrome	0.000181	0.00063	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000181	0.00063	CbGpPWpGaD
Fosaprepitant—Rash—Diazepam—epilepsy syndrome	0.00018	0.00032	CcSEcCtD
Fosaprepitant—Dermatitis—Diazepam—epilepsy syndrome	0.00018	0.000319	CcSEcCtD
Fosaprepitant—Chest pain—Pregabalin—epilepsy syndrome	0.000179	0.000318	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000179	0.000318	CcSEcCtD
Fosaprepitant—Dizziness—Zonisamide—epilepsy syndrome	0.000179	0.000318	CcSEcCtD
Fosaprepitant—Headache—Diazepam—epilepsy syndrome	0.000179	0.000318	CcSEcCtD
Fosaprepitant—Anxiety—Pregabalin—epilepsy syndrome	0.000179	0.000317	CcSEcCtD
Fosaprepitant—Diarrhoea—Clonazepam—epilepsy syndrome	0.000179	0.000317	CcSEcCtD
Fosaprepitant—Anaemia—Gabapentin—epilepsy syndrome	0.000179	0.000317	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000178	0.000316	CcSEcCtD
Fosaprepitant—Hypotension—Valproic Acid—epilepsy syndrome	0.000178	0.000315	CcSEcCtD
Fosaprepitant—Asthenia—Carbamazepine—epilepsy syndrome	0.000178	0.000315	CcSEcCtD
Fosaprepitant—Diarrhoea—Phenytoin—epilepsy syndrome	0.000178	0.000315	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000177	0.000617	CbGpPWpGaD
Fosaprepitant—Discomfort—Pregabalin—epilepsy syndrome	0.000177	0.000314	CcSEcCtD
Fosaprepitant—Nausea—Fosphenytoin—epilepsy syndrome	0.000177	0.000314	CcSEcCtD
Fosaprepitant—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000177	0.000313	CcSEcCtD
Fosaprepitant—Erythema multiforme—Topiramate—epilepsy syndrome	0.000177	0.000313	CcSEcCtD
Fosaprepitant—Angioedema—Gabapentin—epilepsy syndrome	0.000177	0.000313	CcSEcCtD
Fosaprepitant—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000176	0.000313	CcSEcCtD
Fosaprepitant—Vomiting—Felbamate—epilepsy syndrome	0.000176	0.000312	CcSEcCtD
Fosaprepitant—Dry mouth—Pregabalin—epilepsy syndrome	0.000175	0.000311	CcSEcCtD
Fosaprepitant—Pruritus—Carbamazepine—epilepsy syndrome	0.000175	0.000311	CcSEcCtD
Fosaprepitant—Rash—Felbamate—epilepsy syndrome	0.000175	0.000309	CcSEcCtD
Fosaprepitant—Eye disorder—Topiramate—epilepsy syndrome	0.000174	0.000309	CcSEcCtD
Fosaprepitant—Dermatitis—Felbamate—epilepsy syndrome	0.000174	0.000309	CcSEcCtD
Fosaprepitant—Malaise—Gabapentin—epilepsy syndrome	0.000174	0.000309	CcSEcCtD
Fosaprepitant—Tinnitus—Topiramate—epilepsy syndrome	0.000174	0.000309	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000174	0.000604	CbGpPWpGaD
Fosaprepitant—Headache—Felbamate—epilepsy syndrome	0.000173	0.000307	CcSEcCtD
Fosaprepitant—Flushing—Topiramate—epilepsy syndrome	0.000173	0.000307	CcSEcCtD
Fosaprepitant—Cardiac disorder—Topiramate—epilepsy syndrome	0.000173	0.000307	CcSEcCtD
Fosaprepitant—Syncope—Gabapentin—epilepsy syndrome	0.000173	0.000307	CcSEcCtD
Fosaprepitant—Dizziness—Clonazepam—epilepsy syndrome	0.000173	0.000306	CcSEcCtD
Fosaprepitant—Nausea—Vigabatrin—epilepsy syndrome	0.000173	0.000306	CcSEcCtD
Fosaprepitant—Vomiting—Zonisamide—epilepsy syndrome	0.000172	0.000305	CcSEcCtD
Fosaprepitant—Insomnia—Valproic Acid—epilepsy syndrome	0.000172	0.000305	CcSEcCtD
Fosaprepitant—Oedema—Pregabalin—epilepsy syndrome	0.000172	0.000305	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000172	0.000305	CcSEcCtD
Fosaprepitant—Asthenia—Lamotrigine—epilepsy syndrome	0.000172	0.000304	CcSEcCtD
Fosaprepitant—Dizziness—Phenytoin—epilepsy syndrome	0.000172	0.000304	CcSEcCtD
Fosaprepitant—Rash—Zonisamide—epilepsy syndrome	0.000171	0.000303	CcSEcCtD
Fosaprepitant—Infection—Pregabalin—epilepsy syndrome	0.000171	0.000303	CcSEcCtD
Fosaprepitant—Palpitations—Gabapentin—epilepsy syndrome	0.000171	0.000303	CcSEcCtD
Fosaprepitant—Dermatitis—Zonisamide—epilepsy syndrome	0.000171	0.000303	CcSEcCtD
Fosaprepitant—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000171	0.000302	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.00017	0.000592	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CHRM2—epilepsy syndrome	0.00017	0.000592	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.00017	0.000592	CbGpPWpGaD
Fosaprepitant—Nausea—Diazepam—epilepsy syndrome	0.00017	0.000301	CcSEcCtD
Fosaprepitant—Loss of consciousness—Gabapentin—epilepsy syndrome	0.00017	0.000301	CcSEcCtD
Fosaprepitant—Headache—Zonisamide—epilepsy syndrome	0.00017	0.000301	CcSEcCtD
Fosaprepitant—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00017	0.000301	CcSEcCtD
Fosaprepitant—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000169	0.0003	CcSEcCtD
Fosaprepitant—Angiopathy—Topiramate—epilepsy syndrome	0.000169	0.0003	CcSEcCtD
Fosaprepitant—Pruritus—Lamotrigine—epilepsy syndrome	0.000169	0.0003	CcSEcCtD
Fosaprepitant—Shock—Pregabalin—epilepsy syndrome	0.000169	0.0003	CcSEcCtD
Fosaprepitant—Somnolence—Valproic Acid—epilepsy syndrome	0.000169	0.0003	CcSEcCtD
Fosaprepitant—Immune system disorder—Topiramate—epilepsy syndrome	0.000169	0.000299	CcSEcCtD
Fosaprepitant—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000169	0.000299	CcSEcCtD
Fosaprepitant—Cough—Gabapentin—epilepsy syndrome	0.000169	0.000299	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000168	0.000298	CcSEcCtD
Fosaprepitant—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000167	0.000297	CcSEcCtD
Fosaprepitant—Skin disorder—Pregabalin—epilepsy syndrome	0.000167	0.000296	CcSEcCtD
Fosaprepitant—Hypertension—Gabapentin—epilepsy syndrome	0.000167	0.000296	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000166	0.000579	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000166	0.000295	CcSEcCtD
Fosaprepitant—Vomiting—Clonazepam—epilepsy syndrome	0.000166	0.000294	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000166	0.000576	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000165	0.000293	CcSEcCtD
Fosaprepitant—Vomiting—Phenytoin—epilepsy syndrome	0.000165	0.000292	CcSEcCtD
Fosaprepitant—Rash—Clonazepam—epilepsy syndrome	0.000165	0.000292	CcSEcCtD
Fosaprepitant—Dermatitis—Clonazepam—epilepsy syndrome	0.000165	0.000292	CcSEcCtD
Fosaprepitant—Chest pain—Gabapentin—epilepsy syndrome	0.000164	0.000292	CcSEcCtD
Fosaprepitant—Nausea—Felbamate—epilepsy syndrome	0.000164	0.000292	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000164	0.000291	CcSEcCtD
Fosaprepitant—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000164	0.000291	CcSEcCtD
Fosaprepitant—Fatigue—Valproic Acid—epilepsy syndrome	0.000164	0.000291	CcSEcCtD
Fosaprepitant—Anxiety—Gabapentin—epilepsy syndrome	0.000164	0.000291	CcSEcCtD
Fosaprepitant—Dizziness—Carbamazepine—epilepsy syndrome	0.000164	0.00029	CcSEcCtD
Fosaprepitant—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000164	0.00029	CcSEcCtD
Fosaprepitant—Headache—Clonazepam—epilepsy syndrome	0.000164	0.00029	CcSEcCtD
Fosaprepitant—Rash—Phenytoin—epilepsy syndrome	0.000164	0.00029	CcSEcCtD
Fosaprepitant—Mental disorder—Topiramate—epilepsy syndrome	0.000164	0.00029	CcSEcCtD
Fosaprepitant—Dermatitis—Phenytoin—epilepsy syndrome	0.000163	0.00029	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000163	0.00029	CcSEcCtD
Fosaprepitant—Rash—Oxcarbazepine—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Pain—Valproic Acid—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Constipation—Valproic Acid—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Headache—Phenytoin—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Malnutrition—Topiramate—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Erythema—Topiramate—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Discomfort—Gabapentin—epilepsy syndrome	0.000163	0.000288	CcSEcCtD
Fosaprepitant—Headache—Oxcarbazepine—epilepsy syndrome	0.000162	0.000287	CcSEcCtD
Fosaprepitant—Nausea—Zonisamide—epilepsy syndrome	0.000161	0.000285	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AVP—epilepsy syndrome	0.000161	0.00056	CbGpPWpGaD
Fosaprepitant—Dry mouth—Gabapentin—epilepsy syndrome	0.000161	0.000285	CcSEcCtD
Fosaprepitant—Hypotension—Pregabalin—epilepsy syndrome	0.000161	0.000285	CcSEcCtD
Fosaprepitant—Flatulence—Topiramate—epilepsy syndrome	0.00016	0.000284	CcSEcCtD
Fosaprepitant—Dysgeusia—Topiramate—epilepsy syndrome	0.000159	0.000282	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HRH3—epilepsy syndrome	0.000159	0.000552	CbGpPWpGaD
Fosaprepitant—Dizziness—Lamotrigine—epilepsy syndrome	0.000158	0.000281	CcSEcCtD
Fosaprepitant—Oedema—Gabapentin—epilepsy syndrome	0.000158	0.000279	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000158	0.000279	CcSEcCtD
Fosaprepitant—Vomiting—Carbamazepine—epilepsy syndrome	0.000157	0.000279	CcSEcCtD
Fosaprepitant—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000157	0.000278	CcSEcCtD
Fosaprepitant—Infection—Gabapentin—epilepsy syndrome	0.000157	0.000278	CcSEcCtD
Fosaprepitant—Muscle spasms—Topiramate—epilepsy syndrome	0.000156	0.000277	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000156	0.000544	CbGpPWpGaD
Fosaprepitant—Rash—Carbamazepine—epilepsy syndrome	0.000156	0.000277	CcSEcCtD
Fosaprepitant—Dermatitis—Carbamazepine—epilepsy syndrome	0.000156	0.000277	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000156	0.000276	CcSEcCtD
Fosaprepitant—Insomnia—Pregabalin—epilepsy syndrome	0.000156	0.000276	CcSEcCtD
Fosaprepitant—Nausea—Clonazepam—epilepsy syndrome	0.000155	0.000275	CcSEcCtD
Fosaprepitant—Headache—Carbamazepine—epilepsy syndrome	0.000155	0.000275	CcSEcCtD
Fosaprepitant—Shock—Gabapentin—epilepsy syndrome	0.000155	0.000275	CcSEcCtD
Fosaprepitant—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000155	0.000274	CcSEcCtD
Fosaprepitant—Nausea—Phenytoin—epilepsy syndrome	0.000154	0.000273	CcSEcCtD
Fosaprepitant—Dyspnoea—Pregabalin—epilepsy syndrome	0.000153	0.000272	CcSEcCtD
Fosaprepitant—Nausea—Oxcarbazepine—epilepsy syndrome	0.000153	0.000272	CcSEcCtD
Fosaprepitant—Skin disorder—Gabapentin—epilepsy syndrome	0.000153	0.000271	CcSEcCtD
Fosaprepitant—Somnolence—Pregabalin—epilepsy syndrome	0.000153	0.000271	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000152	0.00027	CcSEcCtD
Fosaprepitant—Vomiting—Lamotrigine—epilepsy syndrome	0.000152	0.00027	CcSEcCtD
Fosaprepitant—Urticaria—Valproic Acid—epilepsy syndrome	0.000151	0.000268	CcSEcCtD
Fosaprepitant—Rash—Lamotrigine—epilepsy syndrome	0.000151	0.000267	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000151	0.000267	CcSEcCtD
Fosaprepitant—Dermatitis—Lamotrigine—epilepsy syndrome	0.000151	0.000267	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000151	0.000525	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00015	0.000267	CcSEcCtD
Fosaprepitant—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00015	0.000267	CcSEcCtD
Fosaprepitant—Anaemia—Topiramate—epilepsy syndrome	0.00015	0.000266	CcSEcCtD
Fosaprepitant—Headache—Lamotrigine—epilepsy syndrome	0.00015	0.000266	CcSEcCtD
Fosaprepitant—Decreased appetite—Pregabalin—epilepsy syndrome	0.000149	0.000265	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000148	0.000263	CcSEcCtD
Fosaprepitant—Fatigue—Pregabalin—epilepsy syndrome	0.000148	0.000263	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR3—epilepsy syndrome	0.000148	0.000514	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000147	0.000513	CbGpPWpGaD
Fosaprepitant—Hypotension—Gabapentin—epilepsy syndrome	0.000147	0.000261	CcSEcCtD
Fosaprepitant—Nausea—Carbamazepine—epilepsy syndrome	0.000147	0.000261	CcSEcCtD
Fosaprepitant—Pain—Pregabalin—epilepsy syndrome	0.000147	0.000261	CcSEcCtD
Fosaprepitant—Constipation—Pregabalin—epilepsy syndrome	0.000147	0.000261	CcSEcCtD
Fosaprepitant—Malaise—Topiramate—epilepsy syndrome	0.000147	0.00026	CcSEcCtD
Fosaprepitant—Syncope—Topiramate—epilepsy syndrome	0.000146	0.000258	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NPY—epilepsy syndrome	0.000144	0.0005	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000144	0.0005	CbGpPWpGaD
Fosaprepitant—Palpitations—Topiramate—epilepsy syndrome	0.000144	0.000255	CcSEcCtD
Fosaprepitant—Loss of consciousness—Topiramate—epilepsy syndrome	0.000143	0.000253	CcSEcCtD
Fosaprepitant—Insomnia—Gabapentin—epilepsy syndrome	0.000143	0.000253	CcSEcCtD
Fosaprepitant—Nausea—Lamotrigine—epilepsy syndrome	0.000142	0.000252	CcSEcCtD
Fosaprepitant—Cough—Topiramate—epilepsy syndrome	0.000142	0.000251	CcSEcCtD
Fosaprepitant—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000142	0.000251	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000141	0.000249	CcSEcCtD
Fosaprepitant—Dyspnoea—Gabapentin—epilepsy syndrome	0.000141	0.000249	CcSEcCtD
Fosaprepitant—Hypertension—Topiramate—epilepsy syndrome	0.00014	0.000249	CcSEcCtD
Fosaprepitant—Somnolence—Gabapentin—epilepsy syndrome	0.00014	0.000248	CcSEcCtD
Fosaprepitant—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00014	0.000248	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—AGT—epilepsy syndrome	0.00014	0.000487	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Gabapentin—epilepsy syndrome	0.000139	0.000246	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCL2—epilepsy syndrome	0.000139	0.000483	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CRH—epilepsy syndrome	0.000139	0.000483	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OXT—epilepsy syndrome	0.000139	0.000483	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HSPB1—epilepsy syndrome	0.000139	0.000483	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL3—epilepsy syndrome	0.000139	0.000483	CbGpPWpGaD
Fosaprepitant—Chest pain—Topiramate—epilepsy syndrome	0.000138	0.000245	CcSEcCtD
Fosaprepitant—Anxiety—Topiramate—epilepsy syndrome	0.000138	0.000244	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000137	0.000244	CcSEcCtD
Fosaprepitant—Decreased appetite—Gabapentin—epilepsy syndrome	0.000137	0.000243	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—epilepsy syndrome	0.000137	0.000476	CbGpPWpGaD
Fosaprepitant—Discomfort—Topiramate—epilepsy syndrome	0.000137	0.000242	CcSEcCtD
Fosaprepitant—Urticaria—Pregabalin—epilepsy syndrome	0.000137	0.000242	CcSEcCtD
Fosaprepitant—Asthenia—Valproic Acid—epilepsy syndrome	0.000136	0.000242	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000136	0.000241	CcSEcCtD
Fosaprepitant—Fatigue—Gabapentin—epilepsy syndrome	0.000136	0.000241	CcSEcCtD
Fosaprepitant—Abdominal pain—Pregabalin—epilepsy syndrome	0.000136	0.000241	CcSEcCtD
Fosaprepitant—Body temperature increased—Pregabalin—epilepsy syndrome	0.000136	0.000241	CcSEcCtD
Fosaprepitant—Dry mouth—Topiramate—epilepsy syndrome	0.000135	0.00024	CcSEcCtD
Fosaprepitant—Pain—Gabapentin—epilepsy syndrome	0.000135	0.000239	CcSEcCtD
Fosaprepitant—Constipation—Gabapentin—epilepsy syndrome	0.000135	0.000239	CcSEcCtD
Fosaprepitant—Pruritus—Valproic Acid—epilepsy syndrome	0.000135	0.000239	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000134	0.000466	CbGpPWpGaD
Fosaprepitant—Oedema—Topiramate—epilepsy syndrome	0.000133	0.000235	CcSEcCtD
Fosaprepitant—Infection—Topiramate—epilepsy syndrome	0.000132	0.000234	CcSEcCtD
Fosaprepitant—Shock—Topiramate—epilepsy syndrome	0.000131	0.000231	CcSEcCtD
Fosaprepitant—Diarrhoea—Valproic Acid—epilepsy syndrome	0.00013	0.000231	CcSEcCtD
Fosaprepitant—Nervous system disorder—Topiramate—epilepsy syndrome	0.00013	0.000231	CcSEcCtD
Fosaprepitant—Feeling abnormal—Gabapentin—epilepsy syndrome	0.00013	0.00023	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000129	0.00045	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTK2B—epilepsy syndrome	0.000129	0.000449	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TSC1—epilepsy syndrome	0.000129	0.000449	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000129	0.000229	CcSEcCtD
Fosaprepitant—Skin disorder—Topiramate—epilepsy syndrome	0.000129	0.000228	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000128	0.000227	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AGT—epilepsy syndrome	0.000127	0.000442	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000127	0.000225	CcSEcCtD
Fosaprepitant—Dizziness—Valproic Acid—epilepsy syndrome	0.000126	0.000223	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR2—epilepsy syndrome	0.000125	0.000437	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NTRK2—epilepsy syndrome	0.000125	0.000437	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SST—epilepsy syndrome	0.000125	0.000437	CbGpPWpGaD
Fosaprepitant—Urticaria—Gabapentin—epilepsy syndrome	0.000125	0.000222	CcSEcCtD
Fosaprepitant—Abdominal pain—Gabapentin—epilepsy syndrome	0.000125	0.000221	CcSEcCtD
Fosaprepitant—Body temperature increased—Gabapentin—epilepsy syndrome	0.000125	0.000221	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—DUSP6—epilepsy syndrome	0.000124	0.000433	CbGpPWpGaD
Fosaprepitant—Hypotension—Topiramate—epilepsy syndrome	0.000124	0.00022	CcSEcCtD
Fosaprepitant—Asthenia—Pregabalin—epilepsy syndrome	0.000123	0.000219	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000123	0.000427	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLAT—epilepsy syndrome	0.000122	0.000426	CbGpPWpGaD
Fosaprepitant—Pruritus—Pregabalin—epilepsy syndrome	0.000122	0.000216	CcSEcCtD
Fosaprepitant—Vomiting—Valproic Acid—epilepsy syndrome	0.000121	0.000214	CcSEcCtD
Fosaprepitant—Insomnia—Topiramate—epilepsy syndrome	0.00012	0.000213	CcSEcCtD
Fosaprepitant—Rash—Valproic Acid—epilepsy syndrome	0.00012	0.000213	CcSEcCtD
Fosaprepitant—Dermatitis—Valproic Acid—epilepsy syndrome	0.00012	0.000212	CcSEcCtD
Fosaprepitant—Headache—Valproic Acid—epilepsy syndrome	0.000119	0.000211	CcSEcCtD
Fosaprepitant—Dyspnoea—Topiramate—epilepsy syndrome	0.000118	0.00021	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000118	0.000411	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL12—epilepsy syndrome	0.000118	0.000411	CbGpPWpGaD
Fosaprepitant—Somnolence—Topiramate—epilepsy syndrome	0.000118	0.000209	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—epilepsy syndrome	0.000118	0.00041	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Pregabalin—epilepsy syndrome	0.000118	0.000209	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000117	0.000409	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000117	0.000407	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Topiramate—epilepsy syndrome	0.000117	0.000207	CcSEcCtD
Fosaprepitant—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000116	0.000206	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—JUNB—epilepsy syndrome	0.000116	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CNR1—epilepsy syndrome	0.000116	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLCB1—epilepsy syndrome	0.000115	0.000402	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Topiramate—epilepsy syndrome	0.000115	0.000204	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000115	0.000203	CcSEcCtD
Fosaprepitant—Fatigue—Topiramate—epilepsy syndrome	0.000114	0.000203	CcSEcCtD
Fosaprepitant—Dizziness—Pregabalin—epilepsy syndrome	0.000114	0.000202	CcSEcCtD
Fosaprepitant—Pain—Topiramate—epilepsy syndrome	0.000113	0.000201	CcSEcCtD
Fosaprepitant—Constipation—Topiramate—epilepsy syndrome	0.000113	0.000201	CcSEcCtD
Fosaprepitant—Asthenia—Gabapentin—epilepsy syndrome	0.000113	0.000201	CcSEcCtD
Fosaprepitant—Nausea—Valproic Acid—epilepsy syndrome	0.000113	0.0002	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR7—epilepsy syndrome	0.000113	0.000393	CbGpPWpGaD
Fosaprepitant—Pruritus—Gabapentin—epilepsy syndrome	0.000112	0.000198	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HBEGF—epilepsy syndrome	0.00011	0.000382	CbGpPWpGaD
Fosaprepitant—Vomiting—Pregabalin—epilepsy syndrome	0.000109	0.000194	CcSEcCtD
Fosaprepitant—Feeling abnormal—Topiramate—epilepsy syndrome	0.000109	0.000194	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000108	0.000192	CcSEcCtD
Fosaprepitant—Rash—Pregabalin—epilepsy syndrome	0.000108	0.000192	CcSEcCtD
Fosaprepitant—Dermatitis—Pregabalin—epilepsy syndrome	0.000108	0.000192	CcSEcCtD
Fosaprepitant—Diarrhoea—Gabapentin—epilepsy syndrome	0.000108	0.000191	CcSEcCtD
Fosaprepitant—Headache—Pregabalin—epilepsy syndrome	0.000108	0.000191	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—AKT3—epilepsy syndrome	0.000108	0.000375	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—epilepsy syndrome	0.000107	0.000372	CbGpPWpGaD
Fosaprepitant—Urticaria—Topiramate—epilepsy syndrome	0.000105	0.000187	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADAM10—epilepsy syndrome	0.000105	0.000366	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Topiramate—epilepsy syndrome	0.000105	0.000186	CcSEcCtD
Fosaprepitant—Body temperature increased—Topiramate—epilepsy syndrome	0.000105	0.000186	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—epilepsy syndrome	0.000105	0.000364	CbGpPWpGaD
Fosaprepitant—Dizziness—Gabapentin—epilepsy syndrome	0.000104	0.000185	CcSEcCtD
Fosaprepitant—Nausea—Pregabalin—epilepsy syndrome	0.000102	0.000181	CcSEcCtD
Fosaprepitant—Vomiting—Gabapentin—epilepsy syndrome	0.0001	0.000178	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—S100B—epilepsy syndrome	9.94e-05	0.000346	CbGpPWpGaD
Fosaprepitant—Rash—Gabapentin—epilepsy syndrome	9.94e-05	0.000176	CcSEcCtD
Fosaprepitant—Dermatitis—Gabapentin—epilepsy syndrome	9.93e-05	0.000176	CcSEcCtD
Fosaprepitant—Headache—Gabapentin—epilepsy syndrome	9.88e-05	0.000175	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SOCS3—epilepsy syndrome	9.84e-05	0.000343	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDC42—epilepsy syndrome	9.82e-05	0.000342	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Topiramate—epilepsy syndrome	9.77e-05	0.000173	CcSEcCtD
Fosaprepitant—Asthenia—Topiramate—epilepsy syndrome	9.52e-05	0.000169	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—AVP—epilepsy syndrome	9.51e-05	0.000331	CbGpPWpGaD
Fosaprepitant—Pruritus—Topiramate—epilepsy syndrome	9.39e-05	0.000166	CcSEcCtD
Fosaprepitant—Nausea—Gabapentin—epilepsy syndrome	9.37e-05	0.000166	CcSEcCtD
Fosaprepitant—Diarrhoea—Topiramate—epilepsy syndrome	9.08e-05	0.000161	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HES1—epilepsy syndrome	8.99e-05	0.000313	CbGpPWpGaD
Fosaprepitant—Dizziness—Topiramate—epilepsy syndrome	8.77e-05	0.000155	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—FYN—epilepsy syndrome	8.74e-05	0.000304	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—H2AFX—epilepsy syndrome	8.71e-05	0.000303	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MEF2C—epilepsy syndrome	8.7e-05	0.000303	CbGpPWpGaD
Fosaprepitant—Vomiting—Topiramate—epilepsy syndrome	8.43e-05	0.000149	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.41e-05	0.000293	CbGpPWpGaD
Fosaprepitant—Rash—Topiramate—epilepsy syndrome	8.36e-05	0.000148	CcSEcCtD
Fosaprepitant—Dermatitis—Topiramate—epilepsy syndrome	8.36e-05	0.000148	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NGF—epilepsy syndrome	8.31e-05	0.000289	CbGpPWpGaD
Fosaprepitant—Headache—Topiramate—epilepsy syndrome	8.31e-05	0.000147	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—epilepsy syndrome	8.08e-05	0.000281	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—epilepsy syndrome	7.91e-05	0.000275	CbGpPWpGaD
Fosaprepitant—Nausea—Topiramate—epilepsy syndrome	7.88e-05	0.00014	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TSC2—epilepsy syndrome	7.52e-05	0.000262	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGT—epilepsy syndrome	7.51e-05	0.000261	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOE—epilepsy syndrome	7.36e-05	0.000256	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KDR—epilepsy syndrome	7.21e-05	0.000251	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCB—epilepsy syndrome	6.94e-05	0.000241	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6ST—epilepsy syndrome	6.91e-05	0.00024	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—epilepsy syndrome	6.32e-05	0.00022	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—epilepsy syndrome	6.18e-05	0.000215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGF2—epilepsy syndrome	5.59e-05	0.000194	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RELA—epilepsy syndrome	5.19e-05	0.000181	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MTOR—epilepsy syndrome	5.09e-05	0.000177	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.72e-05	0.000164	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASP3—epilepsy syndrome	4.68e-05	0.000163	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—JUN—epilepsy syndrome	4.54e-05	0.000158	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—epilepsy syndrome	4.42e-05	0.000154	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT1—epilepsy syndrome	4.29e-05	0.000149	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SRC—epilepsy syndrome	4.08e-05	0.000142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—epilepsy syndrome	3.97e-05	0.000138	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT1—epilepsy syndrome	2.53e-05	8.82e-05	CbGpPWpGaD
